Amanda K Gatewood1, Michael J Van Wert2, Andrew P Andrada2, Pamela J Surkan2. 1. Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, United States. Electronic address: akgatewood@jhu.edu. 2. Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, United States.
Abstract
AIMS: To identify perceived barriers to the prescription of naloxone to third-party contacts of opiate users. DESIGN: Qualitative descriptive study. SETTING: Two academic hospitals in Baltimore, MD, USA. PARTICIPANTS: Thirty medical providers, including both physicians and medical students. MEASUREMENTS: Qualitative; in-depth interviews and focus groups analyzed using line-by-line, focused, and axial coding based on methods adapted from grounded theory. FINDINGS: Academic physicians and medical students cited three categories of barriers to naloxone prescription related to drug, provider, and patient characteristics. Concerns about naloxone itself included inability to prevent addictive behaviors, duration of action, medical risks, expiration date, and route of administration. Concerns about medical providers included lack of knowledge or experience, medical community common practices and norms, insufficient provision of third-party education, physician and clinic scheduling practices, worry about insulting patients, and fear of being viewed as enabling drug abuse. Concerns about patients included increased risk-taking behaviors, opiate withdrawal symptoms, potential repeat overdose related to withdrawal-discomfort, decreased contact with medical providers, and stigma. CONCLUSIONS: Minimizing barriers to naloxone provision may increase acceptability and prescription practice in the medical community. Addressing these barriers from multiple provider perspectives is critical to advance naloxone prescription as a harm reduction strategy, which has the potential to prevent opiate overdoses.
AIMS: To identify perceived barriers to the prescription of naloxone to third-party contacts of opiate users. DESIGN: Qualitative descriptive study. SETTING: Two academic hospitals in Baltimore, MD, USA. PARTICIPANTS: Thirty medical providers, including both physicians and medical students. MEASUREMENTS: Qualitative; in-depth interviews and focus groups analyzed using line-by-line, focused, and axial coding based on methods adapted from grounded theory. FINDINGS: Academic physicians and medical students cited three categories of barriers to naloxone prescription related to drug, provider, and patient characteristics. Concerns about naloxone itself included inability to prevent addictive behaviors, duration of action, medical risks, expiration date, and route of administration. Concerns about medical providers included lack of knowledge or experience, medical community common practices and norms, insufficient provision of third-party education, physician and clinic scheduling practices, worry about insulting patients, and fear of being viewed as enabling drug abuse. Concerns about patients included increased risk-taking behaviors, opiate withdrawal symptoms, potential repeat overdose related to withdrawal-discomfort, decreased contact with medical providers, and stigma. CONCLUSIONS: Minimizing barriers to naloxone provision may increase acceptability and prescription practice in the medical community. Addressing these barriers from multiple provider perspectives is critical to advance naloxone prescription as a harm reduction strategy, which has the potential to prevent opiate overdoses.
Authors: Lisa R Gerak; David R Maguire; James H Woods; Stephen M Husbands; Alex Disney; Charles P France Journal: J Pharmacol Exp Ther Date: 2018-11-21 Impact factor: 4.030
Authors: Helen E Jack; Katherine E Warren; Sivakumar Sundaram; Galina Gheihman; John Weems; Ali S Raja; Emily S Miller Journal: AEM Educ Train Date: 2018-03-30
Authors: Daniel Hargraves; Christopher C White; Marcia R Mauger; Aruna Puthota; Harini Pallerla; Patricia Wigle; Sarah L Brubaker; Jeffrey D Schlaudecker Journal: Pharm Pract (Granada) Date: 2019-09-12
Authors: Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Alexander Y Walley; Robin A Pollini Journal: BMC Public Health Date: 2022-04-13 Impact factor: 3.295